(Q37644483)

English

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

scientific article published on 29 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

0 references

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

Gerard Sanacora

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael R Johnson

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Arif Khan

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sarah D Atkinson

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Robert R Riesenberg

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Juan P Schronen

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael A Burke

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

John M Zajecka

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Luis Barra

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Hong-Lin Su

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Joel A Posener

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Khanh H Bui

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael C Quirk

13

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Timothy M Piser

14

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sanjay J Mathew

15

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sanjeev Pathak

16

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

29 September 2016

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

42

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

844-853

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

29 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1038/npp.2016.224

0 references

Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

23 August 2017

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

6 September 2017

The nature of placebo response in clinical studies of major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

6 September 2017

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

6 September 2017

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

6 September 2017

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

6 September 2017

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

14 September 2017

A word to the wise about ketamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

1 September 2018

Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

1 September 2018

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

1 September 2018

A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

1 September 2018

https://api.crossref.org/works/10.1038%2FNPP.2016.224

31 March 2020

Are placebo controls necessary to test new antidepressants and anxiolytics?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5312066

1 September 2018

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2016.224

31 March 2020

Identifiers

10.1038/NPP.2016.224

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37644483&oldid=1850532079"